Canada Markets close in 4 hrs 36 mins

Amryt Pharma plc (AMYT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.80-0.07 (-0.88%)
As of 11:19AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.41
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 312.45
52 Week Low 35.61
50-Day Moving Average 37.40
200-Day Moving Average 38.80

Share Statistics

Avg Vol (3 month) 377.33k
Avg Vol (10 day) 339.67k
Shares Outstanding 563.96M
Implied Shares Outstanding 6N/A
Float 839.48M
% Held by Insiders 10.08%
% Held by Institutions 174.63%
Shares Short (Jul 14, 2022) 4102.7k
Short Ratio (Jul 14, 2022) 40.93
Short % of Float (Jul 14, 2022) 4N/A
Short % of Shares Outstanding (Jul 14, 2022) 40.16%
Shares Short (prior month Jun 14, 2022) 498.56k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 1.31%
Operating Margin (ttm)-11.24%

Management Effectiveness

Return on Assets (ttm)-2.50%
Return on Equity (ttm)1.52%

Income Statement

Revenue (ttm)233.24M
Revenue Per Share (ttm)4.30
Quarterly Revenue Growth (yoy)22.10%
Gross Profit (ttm)120.84M
EBITDA -36M
Net Income Avi to Common (ttm)3.05M
Diluted EPS (ttm)-2.24
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)102.17M
Total Cash Per Share (mrq)1.59
Total Debt (mrq)210.34M
Total Debt/Equity (mrq)60.79
Current Ratio (mrq)1.88
Book Value Per Share (mrq)4.83

Cash Flow Statement

Operating Cash Flow (ttm)5.26M
Levered Free Cash Flow (ttm)-4.35M